Deciphera Pharmaceuticals... (DCPH)
NASDAQ: DCPH
· Real-Time Price · USD
25.59
0.02 (0.08%)
At close: Jun 10, 2024, 10:00 PM
Deciphera Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -190.42M | -194.94M | -193.69M | -187.15M | -181.65M | -178.93M | -221.39M | -258.19M | -285.56M | -299.96M | -274.31M | -258.17M | -254.98M |
Depreciation & Amortization | 3.09M | 2.1M | 2.25M | 2.52M | 2.77M | 2.95M | 3.13M | 3.14M | 3.06M | 3.01M | 2.93M | 2.84M | 2.58M |
Stock-Based Compensation | 48.26M | 50.6M | 48.84M | 50.06M | 50.19M | 51.94M | 50.42M | 49.84M | 49.23M | 46.08M | 44.99M | 43.02M | 41.26M |
Other Working Capital | 1.85M | 12.92M | 4.33M | 4.07M | -10.51M | -28.07M | 13.9M | 21.39M | 42.4M | 33.68M | 2.63M | 12.19M | -4.14M |
Other Non-Cash Items | 23.83M | 2.91M | 1.96M | 1.3M | 1.19M | 2.61M | 3.73M | 8.66M | 8.98M | 9.23M | 9.04M | 4.69M | 3.95M |
Deferred Income Tax | -5.83M | -5.83M | -3.98M | -1.95M | -33K | 222K | 612K | 1.16M | 1.67M | 1.78M | 1.63M | 1.24M | 757K |
Change in Working Capital | -8.65M | -1.54M | -8.43M | -8.85M | -23.43M | -31.65M | -20.99M | -21.73M | -467K | 820K | -5.43M | -10.49M | -19.8M |
Operating Cash Flow | -151.83M | -146.7M | -153.05M | -144.07M | -150.97M | -152.86M | -184.88M | -218.05M | -224.49M | -240.82M | -222.78M | -218.12M | -227M |
Capital Expenditures | -564K | -778K | -983K | -1.49M | -1.49M | -1.13M | 249K | -5.19M | -5.33M | -5.97M | -7.51M | -2.73M | -5.28M |
Cash Acquisitions | -48.38M | -13.33M | -11.06M | 35.9M | 144.46M | 109.41M | 109.41M | 103.91M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -219.98M | -322.57M | -345.09M | -370.02M | -445.63M | -322.77M | -262.25M | -305.14M | -303.55M | -335.38M | -441.48M | -490.71M | -925.07M |
Sales Maturities Of Investments | 331.13M | 335.9M | 372.44M | 350.4M | 317.45M | 289.3M | 310.35M | 379.19M | 421.48M | 518.2M | 573.94M | 605.76M | 1.09B |
Other Investing Acitivies | 111.16M | 13.33M | 11.35M | -35.61M | -144.17M | -109.12M | -109.41M | -107.91M | -4.01M | -4.01M | -4.98M | -970K | -971K |
Investing Cash Flow | 110.59M | 12.55M | 26.65M | -20.82M | -129.38M | -34.31M | 48.34M | 68.85M | 112.59M | 176.85M | 123.97M | 111.36M | 154.06M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 17.84M | 152M | 151.59M | 136.21M | 299.6M | 164.99M | 166.49M | 167.99M | 5.45M | 14.89M | 40.7M | 42.23M | 44.93M |
Financial Cash Flow | 17.84M | 152M | 151.59M | 136.21M | 299.6M | 164.99M | 166.49M | 167.99M | 5.45M | 14.89M | 40.7M | 42.23M | 44.93M |
Net Cash Flow | -23.41M | 18.77M | 25.55M | -28.3M | 19.3M | -22.32M | 29.35M | 18.75M | -106.32M | -48.83M | -57.97M | -64.5M | -28M |
Free Cash Flow | -152.39M | -147.47M | -154.03M | -145.56M | -152.45M | -153.99M | -184.63M | -223.24M | -229.83M | -246.79M | -230.28M | -220.85M | -232.28M |